02:08:58 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-29 Ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 Ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2022-08-24 15:36:29
OSLO, NORWAY - 24 August 2022. On 24 August 2022 Circa Group AS (the "Company")
have allocated share options in the Company to the following primary insiders in
accordance with the Company's Long Term Incentive (LTI) program:

Director Trond Stangeby 50,000 LTI options with strike price NOK 16.75
Director Greg Court 50,000 LTI options with strike price NOK 16.75
Director Martin Laudenbach 50,000 LTI options with strike price NOK 8.6032
Director Elise Fahlén 50,000 LTI options with strike price NOK 8.6032
Global Head of Production Philipp Morgenthaler 200,000 LTI options with strike
price NOK 7.4332
Group General Counsel Jens Even Højlund Pedersen 50,000 LTI options with strike
price NOK 7.4332



Please refer to the attached notifications of transactions for further details.

About Circa
Established in 2006, Circa Group converts non-food biomass into advanced
bio-based chemicals with its proprietary FuracellTM process. Its developing
product portfolio includes flavours, biopolymers, and bio-solvents including
CyreneTM, an alternative to traditional polar aprotic solvents, which is produced
in one step from platform biomolecule Levoglucosenone. By creating renewable
chemicals from cellulose, Circa is extracting value from non-food biomass and
addressing a gap in the market by providing bio-based alternatives contributing
to a more circular economy. In March 2021, Circa Group successfully listed on
the Euronext Growth Market in Oslo, stock symbol CIRCA.
www.circa-group.com


Investor Contact Circa Group

Tone Leivestad, Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455

Media Contact
Scott Engebrigtsen
Hill and Knowlton Strategies
Scott.Engebrigtsen@hkstrategies.com
Tel: +47 900 43 484